Skip to main content
. 2021 Mar 11;12:605945. doi: 10.3389/fimmu.2021.605945

Table 4.

Treatment modalities used in the CVID patients with ILD in the study.

Corticosteroids 23 patients (50.0%)
Rituximab 16 patients (34.8%)
Mycophenolate mofetil 5 patients (10.9%)
Azathioprine 4 patients (8.7%)
Mercaptopurine 2 patients (4.3%)
Hydroxychloroquine 2 patients (4.3%)
Abatacept 1 patient (2.2%)
Sirolimus 1 patient (2.2%)
Cyclosporine 1 patient (2.2%)